Late cognitive and adaptive outcomes of patients with neuroblastoma‐associated opsoclonus‐myoclonus‐ataxia‐syndrome: A report from the Children's Oncology Group

Ejemplares similares

• Enrollment on upfront high‐risk neuroblastoma trials by race, ethnicity, and poverty status: A report from the Children's Oncology Group
  por: Puja J. Umaretiya, et al.
  Publicado: (2024)
• Long‐term follow‐up of patients with intermediate‐risk neuroblastoma treated with response‐ and biology‐based therapy: A report from the Children's Oncology Group study ANBL0531
  por: Erin K. Barr, et al.
  Publicado: (2024)
• Outcomes of patients with intermediate‐risk neuroblastoma presenting with motor deficits relating to intraspinal tumor extension: A report from the Children's Oncology Group study ANBL0531
  por: Julie Voeller, et al.
  Publicado: (2024)
• Long‐Term Outcome of Young Infants With Suspected Neuroblastoma following Observation as Primary Therapy: A Report From the Children's Oncology Group
  por: Hetal Dholaria, et al.
  Publicado: (2025)
• Higher tumor mutational burden is associated with inferior outcomes among pediatric patients with neuroblastoma
  por: Ya‐Hsuan Chang, et al.
  Publicado: (2024)